The Basel Institute’s Collective Action team has facilitated the co-development of a set of indicators that health care companies may wish to consider when reporting on the effectiveness of their anti-corruption efforts to external stakeholders.
The guidance note containing the indicators was developed over seven months by a group of health care companies under an innovative project of Norges Bank Investment Management.